BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 24500503)

  • 1. Molecular expression of adiponectin in human saliva.
    Lin H; Maeda K; Fukuhara A; Shimomura I; Ito T
    Biochem Biophys Res Commun; 2014 Mar; 445(2):294-8. PubMed ID: 24500503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High molecular weight adiponectin correlates positively with myeloperoxidase in patients with type 2 diabetes mellitus.
    Bobbert P; Rauch U; Stratmann B; Goldin-Lang P; Antoniak S; Bobbert T; Schultheiss HP; Tschoepe D
    Diabetes Res Clin Pract; 2008 Nov; 82(2):179-84. PubMed ID: 18778866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of adiponectin and C1q in human serum, and clinical significance of the measurement of C1q-adiponectin / total adiponectin ratio.
    Nakatsuji H; Kobayashi H; Kishida K; Nakagawa T; Takahashi S; Tanaka H; Akamatsu S; Funahashi T; Shimomura I
    Metabolism; 2013 Jan; 62(1):109-20. PubMed ID: 22819529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of salivary resistin, visfatin and adiponectin levels.
    Mamali I; Roupas ND; Armeni AK; Theodoropoulou A; Markou KB; Georgopoulos NA
    Peptides; 2012 Jan; 33(1):120-4. PubMed ID: 22108712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic changes in plasma total and high molecular weight adiponectin levels in acute heart failure.
    Ohara T; Hashimura K; Asakura M; Ogai A; Amaki M; Hasegawa T; Kanzaki H; Sonoda M; Nishizawa H; Funahashi T; Kitakaze M
    J Cardiol; 2011 Sep; 58(2):181-90. PubMed ID: 21824750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adiponectin multimerization is dependent on conserved lysines in the collagenous domain: evidence for regulation of multimerization by alterations in posttranslational modifications.
    Richards AA; Stephens T; Charlton HK; Jones A; Macdonald GA; Prins JB; Whitehead JP
    Mol Endocrinol; 2006 Jul; 20(7):1673-87. PubMed ID: 16497731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced circulating oxytocin and High-Molecular-Weight adiponectin are risk factors for metabolic syndrome.
    Yuan G; Qian W; Pan R; Jia J; Jiang D; Yang Q; Wang S; Liu Y; Yu S; Hu H; Sun W; Ye J; Mao C; Zhuang R; Zhou L
    Endocr J; 2016 Jul; 63(7):655-62. PubMed ID: 27237400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel ELISA system for selective measurement of human adiponectin multimers by using proteases.
    Ebinuma H; Miyazaki O; Yago H; Hara K; Yamauchi T; Kadowaki T
    Clin Chim Acta; 2006 Oct; 372(1-2):47-53. PubMed ID: 16697359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of saliva sampling methods for measurement of salivary adiponectin levels.
    Toda M; Morimoto K
    Scand J Clin Lab Invest; 2008; 68(8):823-5. PubMed ID: 18618368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained High Levels of Both Total and High Molecular Weight Adiponectin in Plasma during the Convalescent Phase of Haemorrhagic Fever with Renal Syndrome Are Associated with Disease Severity.
    Tang K; Zhang C; Zhang Y; Zhang Y; Zhuang R; Jin B; Ma Y
    J Immunol Res; 2017; 2017():6468097. PubMed ID: 28424792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced high-molecular-weight adiponectin is an independent risk factor for cardiovascular lesions in hypercholesterolaemic patients.
    Wang W; Xing W; Zhang H; Ding M; Shang L; Lau WB; Wang X; Li R
    Clin Endocrinol (Oxf); 2013 Apr; 78(4):539-44. PubMed ID: 22612653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction Levels and the Effects of High-Molecular-Weight Adiponectin via AMPK/eNOS in Chinese Type 2 Diabetes.
    Lian K; Guo X; Huang Q; Tan Z; Xia C; Wang R; Yi F; Li W; Liu J; Li Y; Guo S; Wang H; Ji Q; Tao L
    Exp Clin Endocrinol Diabetes; 2016 Oct; 124(9):541-547. PubMed ID: 27437915
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of salivary adiponectin profile in obese patients.
    Nigro E; Piombino P; Scudiero O; Monaco ML; Schettino P; Chambery A; Daniele A
    Peptides; 2015 Jan; 63():150-5. PubMed ID: 25481860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement and validation of the nature of salivary adiponectin.
    Akuailou EN; Vijayagopal P; Imrhan V; Prasad C
    Acta Diabetol; 2013 Oct; 50(5):727-30. PubMed ID: 22415037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adiponectin downregulates its own production and the expression of its AdipoR2 receptor in transgenic mice.
    Bauche IB; Ait El Mkadem S; Rezsohazy R; Funahashi T; Maeda N; Miranda LM; Brichard SM
    Biochem Biophys Res Commun; 2006 Jul; 345(4):1414-24. PubMed ID: 16729974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of ELISA for specific measurement of high-molecular-weight (HMW) adiponectin.
    Tanita T; Miyakoshi H; Nakano Y
    J Immunol Methods; 2008 Apr; 333(1-2):139-46. PubMed ID: 18304569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High molecular weight multimer form of adiponectin as a useful marker to evaluate insulin resistance and metabolic syndrome in Japanese men.
    Seino Y; Hirose H; Saito I; Itoh H
    Metabolism; 2007 Nov; 56(11):1493-9. PubMed ID: 17950099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating levels of adiponectin and extent of coronary artery disease in patients undergoing elective coronary angiography.
    Souza RA; Alves CMR; de Oliveira CSV; Reis AF; Carvalho AC
    Braz J Med Biol Res; 2017 Nov; 51(2):e6738. PubMed ID: 29211251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-molecular weight adiponectin isoforms increase after biliopancreatic diversion in obese subjects.
    Salani B; Briatore L; Andraghetti G; Adami GF; Maggi D; Cordera R
    Obesity (Silver Spring); 2006 Sep; 14(9):1511-4. PubMed ID: 17030961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of salivary adiponectin levels.
    Toda M; Tsukinoki R; Morimoto K
    Acta Diabetol; 2007 Mar; 44(1):20-2. PubMed ID: 17357881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.